The influence of psychopharmacological treatment in the long-term outcome in patients suffering ADH with comorbid drug use - 13/04/16
Résumé |
ADH is one of mental disease with a higher prevalence of alcohol and drug abuse. ADH is a risk factor for drug use, and that's true in the reverse sense. The mutual influence in both disorders is clear and the presence of both disorders together could be a real challenge for a clincial professional.
The main objective of the study is to evaluate the influence of the psychopharmacological treatment in the longterm outcome of this sample, using a measurement drug use, adherence to the treatment and impulsivity.
We make a study that includes a group of patients with both disorders. We select a sample from the Centro de Día Zuría. The patients complete a battery of scales (SCL-90, BArratt, SF-36) before and after the beginning of psychopharmacological treatment.
Our results shows a better prognosis in the patients with a good adherence to treatment, with a decrease in frequency and levels of drug use and a decrease in impulsivity, with a low level of behavioral disorders and violence.
Le texte complet de cet article est disponible en PDF.Plan
Vol 33 - N° S
P. S382 - mars 2016 Retour au numéro
Article précédent
- Prevalence and clinical correlates of comorbid drug use and ADH
- L. Reula, A. Portilla Fernández, E. Manrique Astiz, L.A. Núñez Domínguez, O. Arbeo Ruiz, M. Gracía Nicolás, O. Fernández de la Vega
- Between Scylla and Charybdis: Where does the treatment of Addison's disease in late-life depression go first?
- S. Petrykiv, M. Arts, L. de Jonge
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?